This is current information in SEC docs. Probably more reliable than PRs that are almost 10 years old when Oncolix was a private company with grants from the Susan G. Komen Foundation and the U.S. governement.
LOL nope. It didn’t happen.
Dale is not an Oncolix employee, he is an uncompensated BOD member.
He represents a 10,000,000 share voting block owned by the BioVectra parent company Mallinckrodt PLC NYSE: MNK.
NYSE:MNK subsidiary Biovectra holds 10,000,000 common shares of ONCX with no preferreds to offset future dilution or common stock reverse splits as predicted by some.
If I am gonna be a loser victim of a LARP, so will NYSE:MNK, the ONCX CEO, Michael Redman and dozens of accredited investors, who some claim are willing to surrender their control of the company to a few note holders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.